510(k) K233293

Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System® by Neurosigma, Inc. — Product Code QGL

K233293 is an FDA 510(k) premarket notification submitted by Neurosigma, Inc. for the device "Generation 2.0 Monarch external Trigeminal Nerve Stimulation (eTNS) System®". The FDA issued a decision of Substantially Equivalent on Jan 16, 2024. The device falls under product code QGL (Transcutaneous Nerve Stimulator For Adhd), a Class II device regulated under 21 CFR 882.5898. Neurosigma, Inc. has 1 other 510(k) clearance on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 16, 2024
Date Received
Sep 29, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Transcutaneous Nerve Stimulator For Adhd
Device Class
Class II
Regulation Number
882.5898
Review Panel
NE
Submission Type
510(k)

A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.

Need the full FDA record for Neurosigma, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K233293. Report a data issue: hello@regdatalab.com.